Rite Aid Pharmacy 10308 Durable Medical Equipment & Medical Supplies Location: 1823 Vermont Rt 107 #2, Bethel, Vermont 05032 Phone: (802) 234-5289 |
News Archive
While The Wall Street Journal and Kaiser Health News report on the current dark side of aging in America, The Associated Press offers insights into how baby boomer interest in countering the effects of getting older could lead to billions of dollars in spending.
Pfizer Inc. today announced that the ORAL Sync Phase 3 study of tofacitinib, formerly known as tasocitinib, an investigational, novel, oral JAK inhibitor, being studied in moderate-to-severe rheumatoid arthritis, met its primary endpoints by showing statistically significant changes versus placebo in reducing signs and symptoms of RA, as measured by ACR20 response rates at six months; in improving physical function, as measured by mean change in HAQ DI at three months; and in reaching DAS28-4 <2.6 at six months.
"We strongly support comprehensive, bipartisan health care reform that covers all Americans, improves quality, and puts the health care system on an affordable, sustainable path. Health plans have proposed guaranteed coverage, elimination of pre-existing condition exclusions, and no longer basing premiums on health status or gender. Experience in the states has shown that market reforms need to paired with universal coverage to make health care as affordable as possible.
A team of researchers from the Northern Arizona University evaluated a new PARP inhibitor, stenoparib, which has recently advanced to Stage II of clinical trials to treat ovarian cancer. Their study, an initial report on in vitro stenoparib activity against human coronaviruses such as SARS-CoV-2, has been published on the preprint server bioRxiv*.
Mitek Sports Medicine, part of DePuy Synthes Companies of Johnson & Johnson, is introducing two new arthroscopic surgery radiofrequency devices this week at the American Orthopaedic Society for Sports Medicine 2015 Annual Meeting.
› Verified 5 days ago